Platinum Compound: clinical trials recruiting now

Fewer than 3 recruiting trials found.

2

Recruiting trials

15

Conditions studied

32

US states with sites

2

Countries

Phase breakdown

Phase 1 1 Phase 2 1

Conditions being studied

Condition	Trials
Autoimmune Disease	1
Crohn Disease	1
Crohn's disease	1
Dermatomyositis	1
Extensive Stage Lung Small Cell Carcinoma	1
Hematopoietic and Lymphoid Cell Neoplasm	1
Inflammatory Bowel Disease	1
Lung Small Cell Carcinoma, A Subtype	1
Lung Small Cell Carcinoma, I Subtype	1
Lung Small Cell Carcinoma, N Subtype	1
Lung Small Cell Carcinoma, P Subtype	1
Lung cancer	1
Lupus	1
Malignant Solid Neoplasm	1
Multiple Sclerosis	1

Recruiting trials involving Platinum Compound

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
NCT03816345 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 260 locations
Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study
NCT06769126 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 148 locations

Common questions

How many recruiting trials involve Platinum Compound?

2 recruiting trials across 15 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.